According to the data of the European Surveillance, a decrease of 10% is seen in the cases of one of the most severe diseases known as Hepatitis C during the… Continue Reading
Blogs
390 Cancer drugs to become cheaper in India, NPPA caps trade margin of 42 drugs
Cancer drugs to become cheaper in India Recently NPPA caps trade margins for 42 anti-cancer drugs. This is very good initiatives taken by the government. As per the government now… Continue Reading
Natco Pharma launches VALSAC (Valsartan Sacubitril) Generic Entresto in India
On January 2019, Natco Pharma has launched a cardiac drug Valsartan-Sacubitril tablet at an affordable price, under its brand VALSAC in India. VALSAC (Valsartan Sacubitril) is a combination heart drug…. Continue Reading
Natco Pharma applying for generic version of ibrutinib cancer drug
Indian leading generic drug manufacturer, Natco pharma submits the generic version of ibrutinib drug approval application to USFDA. The strength would be 140 mg, 280 mg, 420 mg and 560… Continue Reading
Hetero Launches Generic Lapatinib ‘Hertab’ a Breast Cancer Treatment Drug in India
11th January 2019, Hyderabad, India: Hetero, one of India’s leading Indian generic pharmaceutical company and the globally biggest manufacturer of anti-retroviral drugs, announce the release of generic version of Lapatinib… Continue Reading